1701
|
|
|
Cytochrome b561 family member A3 |
CYBASC3, LCYTB |
|
1702
|
|
|
Cytochrome b561 family member D1 |
- |
|
1703
|
|
|
Cytochrome b561 family member D2 |
101F6, TSCytb, TSP10, XXcos-LUCA11.4 |
|
1704
|
|
|
Cytochrome b5 type A |
CYB5, MCB5, METAG |
|
1705
|
|
|
Cytochrome b5 type B |
CYB5-M, CYPB5M, OMB5 |
Cardiovascular disease, Cataract, Cholecystolithiasis, Coronary artery disease, Diabetes mellitus, Gallstones, Gout, Heart failure, Metabolic syndrome, Osteoarthritis, Peripheral arterial disease, Peripheral vascular disease, Diabetes mellitus type 2, Vascular disease |
1706
|
|
|
Cytochrome b5 domain containing 2 |
- |
|
1707
|
|
|
Cytochrome b5 reductase 1 |
B5R.1, B5R1, B5R2, NQO3A2, humb5R2 |
|
1708
|
|
|
Cytochrome b5 reductase 2 |
B5R.2 |
|
1709
|
|
|
Cytochrome b5 reductase 3 |
B5R, DIA1 |
Congenital myopathy, Congenital methemoglobinemia, Cyanosis, Cytochrome-b5 reductase deficiency, Dihydrolipoamide dehydrogenase deficiency, Intellectual developmental disorder, Methemoglobinemia, Osteoarthritis, Scoliosis, Diabetes mellitus type 2, Venous thromboembolism |
1710
|
|
|
Cytochrome b5 reductase 4 |
NCB5OR, cb5/cb5R, dJ676J13.1 |
|